標(biāo)題: Titlebook: Core Concepts in Hypertension in Kidney Disease; Ajay K. Singh,Rajiv Agarwal Book 2016 Springer Science+Business Media, LLC, part of Sprin [打印本頁] 作者: digestive-tract 時(shí)間: 2025-3-21 17:01
書目名稱Core Concepts in Hypertension in Kidney Disease影響因子(影響力)
書目名稱Core Concepts in Hypertension in Kidney Disease影響因子(影響力)學(xué)科排名
書目名稱Core Concepts in Hypertension in Kidney Disease網(wǎng)絡(luò)公開度
書目名稱Core Concepts in Hypertension in Kidney Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Core Concepts in Hypertension in Kidney Disease被引頻次
書目名稱Core Concepts in Hypertension in Kidney Disease被引頻次學(xué)科排名
書目名稱Core Concepts in Hypertension in Kidney Disease年度引用
書目名稱Core Concepts in Hypertension in Kidney Disease年度引用學(xué)科排名
書目名稱Core Concepts in Hypertension in Kidney Disease讀者反饋
書目名稱Core Concepts in Hypertension in Kidney Disease讀者反饋學(xué)科排名
作者: Nomadic 時(shí)間: 2025-3-21 22:21 作者: 拔出 時(shí)間: 2025-3-22 00:57
Armir Bujari,Claudio E. Palazzigency/emergency are reviewed, including preferred therapies for specific clinical scenarios. Recognizing a true hypertensive urgency and emergency, treating the patient safely, but quickly, and determining the cause of escalated blood pressure are pivotal.作者: Anticoagulants 時(shí)間: 2025-3-22 07:08
Book 2016ner, the focus of this volume is on various therapies and how to lower blood pressure through lifestyle changes. ?Specialist patient populations and hypertension and causes of hypertension are also covered in detail. ?Clinically-focused and authoritative, this resource offers a rationalized approach作者: bioavailability 時(shí)間: 2025-3-22 12:34 作者: ARENA 時(shí)間: 2025-3-22 15:14
Armir Bujari,Claudio E. Palazzi and management of hypertension in pregnancy requires a special approach with attention toward the maternal and fetal effects of both the disease and the treatment. This chapter reviews the pathogenesis, epidemiology, diagnosis, management, and prognosis of hypertensive disorders of pregnancy.作者: ARENA 時(shí)間: 2025-3-22 18:11
Armir Bujari,Claudio E. Palazzipes have identified novel pathways exclusively linked to renal sodium wasting. The investigation and understanding of rare inherited syndromes of renal hypertension have important implications on improving both diagnosis and treatment of hypertension in the general population.作者: Osteons 時(shí)間: 2025-3-22 23:30 作者: Notify 時(shí)間: 2025-3-23 02:59 作者: morale 時(shí)間: 2025-3-23 06:43
Drug-Induced Hypertension in Chronic Kidney Disease,scribed and over-the-counter medications that are commonly used by patients with CKD. Targeting and controlling risks that can potentially cause harm is central to the role of the healthcare provider. For this reason understanding which drugs are implicated in hypertension is imperative for any provider managing a patient with CKD.作者: 興奮過度 時(shí)間: 2025-3-23 13:08
Assessment of Hypertension in Chronic Kidney Disease,e, thus representing the preferred method for the diagnosis of hypertension. Although clinical trial evidence to support the use of home and ambulatory BP to guide treatment among patients with chronic kidney disease is sparse, observational data suggest that these techniques add value to the management of hypertensive patients.作者: extemporaneous 時(shí)間: 2025-3-23 17:30 作者: Regurgitation 時(shí)間: 2025-3-23 20:25
ugh lifestyle changes. ?Specialist patient populations and hypertension and causes of hypertension are also covered in detail. ?Clinically-focused and authoritative, this resource offers a rationalized approach to diagnosing and treating hypertension in CKD..978-1-4939-8199-1978-1-4939-6436-9作者: 無情 時(shí)間: 2025-3-23 22:37 作者: Externalize 時(shí)間: 2025-3-24 03:01 作者: Overdose 時(shí)間: 2025-3-24 09:51
David S. Rosenblatt,Jennifer Fitzpatrick evolves as does secondary hypertension. Multiple pathologies can cause renal artery stenosis, mostly commonly atherosclerotic renovascular disease (ARVD), followed by fibromuscular disease (FMD). It is important to differentiate between the various types of renovascular disease, since each has its 作者: 人類 時(shí)間: 2025-3-24 11:15
Spiritual Dimensions of Whole Person Care,uggesting that resistant hypertension is strongly associated with elevated risks for adverse cardiovascular outcomes and progression to end-stage-renal-disease both in the general hypertensive population and in CKD. Before making the diagnosis of resistant hypertension, common factors related to pse作者: 含水層 時(shí)間: 2025-3-24 18:33
Prevention and Whole Person Care,ociated with improved eGFR. ACE inhibitors and angiotensin receptor blockers are not recommended in the first 3-6 months given their effects on reduced eGFR, anemia and hyperkalemia. The use of ?blockers may be associated with improved patient survival, even for patients with no history of cardiovas作者: neutral-posture 時(shí)間: 2025-3-24 22:18 作者: Infect 時(shí)間: 2025-3-24 23:55 作者: 沒花的是打擾 時(shí)間: 2025-3-25 03:42
Armir Bujari,Claudio E. Palazziniversal blood pressure-lowering response with device therapy—patient subgroups that are more likely to respond need to be identified, and practical clinical markers that can assess adequacy of the intervention are needed. It should also be noted that none of the device therapies are currently appro作者: intrude 時(shí)間: 2025-3-25 10:34 作者: bioavailability 時(shí)間: 2025-3-25 12:59 作者: 相符 時(shí)間: 2025-3-25 19:04 作者: Iniquitous 時(shí)間: 2025-3-25 23:46
Resistant Hypertension in Chronic Kidney Disease,uggesting that resistant hypertension is strongly associated with elevated risks for adverse cardiovascular outcomes and progression to end-stage-renal-disease both in the general hypertensive population and in CKD. Before making the diagnosis of resistant hypertension, common factors related to pse作者: grotto 時(shí)間: 2025-3-26 03:44 作者: Sedative 時(shí)間: 2025-3-26 06:37
Management of Hypertension in Chronic Kidney Disease,s of antihypertensive medications. Furthermore, the specific management of certain subgroups of patients, such as those with proteinuria and the elderly, remains a point of ongoing controversy. In this chapter, we review the existing evidence and most recent guidelines for the optimum blood pressure作者: Thyroid-Gland 時(shí)間: 2025-3-26 09:37
Diagnosis and Management of Hypertension in Children with Chronic Kidney Disease,the renin–angiotensin–aldosterone system (RAAS) should be considered first-line therapy in CKD-associated hypertension in children, though multiple medications may be required to achieve sufficient BP control.作者: enhance 時(shí)間: 2025-3-26 16:15 作者: ABIDE 時(shí)間: 2025-3-26 20:08
Ajay K. Singh,Rajiv AgarwalCovers the pathophysiology, diagnosis and treatment of hypertension in chronic kidney disease.Examines hypertension in different patient populations and clinical settings.Ideal for the busy practicing作者: BLOT 時(shí)間: 2025-3-26 23:10
http://image.papertrans.cn/c/image/238231.jpg作者: Institution 時(shí)間: 2025-3-27 03:26 作者: 瘋狂 時(shí)間: 2025-3-27 05:52
3G Wireless Communication Systems,ic precepts to generate accurate readings. Home and ambulatory BP monitoring provide greater reliability and reproducibility than office readings and are associated with greater ability to predict hypertension-related outcomes in patients with hypertension, including those with chronic kidney diseas作者: 單挑 時(shí)間: 2025-3-27 13:16 作者: Flirtatious 時(shí)間: 2025-3-27 13:46 作者: nostrum 時(shí)間: 2025-3-27 21:27 作者: Ventilator 時(shí)間: 2025-3-27 23:30
Armir Bujari,Claudio E. Palazzirders of pregnancy include four categories: chronic hypertension, gestational hypertension, preeclampsia, and superimposed preeclampsia. The diagnosis and management of hypertension in pregnancy requires a special approach with attention toward the maternal and fetal effects of both the disease and 作者: 群島 時(shí)間: 2025-3-28 03:06 作者: Interlocking 時(shí)間: 2025-3-28 08:31
Armir Bujari,Claudio E. Palazziogy, and approach to patients with hypertensive urgencies and emergencies are discussed. The specific approach to the chronic kidney disease population is also outlined throughout the chapter, including various case illustrations. Oral and parenteral medications used specifically for hypertensive ur作者: PAEAN 時(shí)間: 2025-3-28 11:53 作者: infinite 時(shí)間: 2025-3-28 17:48 作者: 內(nèi)行 時(shí)間: 2025-3-28 21:31
Armir Bujari,Claudio E. Palazzid to be a strong risk factor for cardiovascular complications such as stroke, myocardial infarction, and progression to end-stage renal disease. Medications commonly used by patients with CKD to manage pain, inflammatory syndromes, mood disorders, anemia, cancer, and other conditions can cause raise作者: 倫理學(xué) 時(shí)間: 2025-3-29 01:41
Armir Bujari,Claudio E. Palazziarkers of cardiovascular disease and neurocognitive functioning. Recent studies have demonstrated that the prevalence of hypertension in this population is higher than previously thought, and frequently underdiagnosed and undertreated. Identifying and treating hypertension in children with CKD requi作者: 阻止 時(shí)間: 2025-3-29 05:12
Armir Bujari,Claudio E. Palazzi to be as high as 23 % in CKD, and prevalence increases as the estimated glomerular filtration rate (eGFR) declines. Suboptimal control rates of hypertension and limited advances in pharmacologic options have increased interest in the use of device therapy as potential complementary or alternative t作者: 憲法沒有 時(shí)間: 2025-3-29 08:56
https://doi.org/10.1007/978-1-4939-6436-9chronic kidney disease; hypertension; dialysis; assessment of kidney disease; kidney transplant作者: 改正 時(shí)間: 2025-3-29 14:39 作者: Pituitary-Gland 時(shí)間: 2025-3-29 18:50 作者: 善于 時(shí)間: 2025-3-29 23:06
Hypertension in the Dialysis Patient,Hypertension is common, difficult to diagnose, and poorly controlled in dialysis patients. There remains controversy on the diagnosis, treatment, and prognosis of hypertension in dialysis. This chapter describes the latest evidence on epidemiology, diagnosis, management, and prognosis of hypertension in dialysis.作者: 津貼 時(shí)間: 2025-3-30 03:18 作者: 有害 時(shí)間: 2025-3-30 04:11
Epidemiology of Hypertension in Chronic Kidney Disease, of CKD ranges between 8 and 16 % of adult population worldwide. Hypertension is ranked the leading risk factor for death and disability-adjusted life years lost in 2010 and nearly a billion (26.4 %) of the adult population has hypertension. The relationship between hypertension and chronic kidney d作者: MULTI 時(shí)間: 2025-3-30 08:33 作者: 種植,培養(yǎng) 時(shí)間: 2025-3-30 13:56
Pathophysiology of Hypertension in Chronic Kidney Disease and Dialysis,uid volumes and BP homeostasis. Kidney disease, regardless of etiology, tends to impair the efficiency of the salt excretory mechanisms albeit to a variable degree. This results in an increased BP salt sensitivity with a general potentiation of the prohypertensive mechanisms and a blunting of the ef作者: Canvas 時(shí)間: 2025-3-30 20:32 作者: 頭盔 時(shí)間: 2025-3-31 00:19
Resistant Hypertension in Chronic Kidney Disease,ations including a diuretic, is a common disorder with an estimated prevalence of around 9–12 % in the general hypertensive population. Although chronic kidney disease (CKD) has long been considered as a major underlying cause of resistance to antihypertensive therapy, only recent epidemiological da作者: 預(yù)兆好 時(shí)間: 2025-3-31 01:33
Hypertension in Pregnancy,rders of pregnancy include four categories: chronic hypertension, gestational hypertension, preeclampsia, and superimposed preeclampsia. The diagnosis and management of hypertension in pregnancy requires a special approach with attention toward the maternal and fetal effects of both the disease and 作者: Ablation 時(shí)間: 2025-3-31 05:19 作者: Oafishness 時(shí)間: 2025-3-31 12:11
Hypertensive Urgencies and Emergencies,ogy, and approach to patients with hypertensive urgencies and emergencies are discussed. The specific approach to the chronic kidney disease population is also outlined throughout the chapter, including various case illustrations. Oral and parenteral medications used specifically for hypertensive ur作者: 預(yù)兆好 時(shí)間: 2025-3-31 15:12
Management of Hypertension in Chronic Kidney Disease,es the risk of adverse cardiovascular and cerebrovascular outcomes. Consequently, close attention to the appropriate management of elevated blood pressure in these patients is critical. However, the complex relationship between blood pressure and renal function contributes to uncertainty regarding o
